The three cases with SV PPA due to FTLD-TDP (cases 8–10) showed milder AD tau pathology compared with the cases with underlying AD pathology (Table 1: Braak NFT stage I-II vs. VI). This evidence concerns the gene MAPT and Alzheimer disease.